Assessing the Effectiveness of Valbenazine in the Treatment of Tardive Dyskinesia as Determined by the AIMS and PGIC: Results from the KINECT 4 Trial

Need to get in touch with us?

medinfo@neurocrine.com
1-877-641-3461